Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2024

May 10, 2024

BUY
$191.17 - $325.63 $191,170 - $325,630
1,000 New
1,000 $325,000
Q3 2023

Oct 20, 2023

BUY
$194.33 - $283.97 $38,866 - $56,794
200 Added 28.57%
900 $179,000
Q2 2023

Aug 01, 2023

BUY
$223.05 - $302.68 $156,135 - $211,876
700 New
700 $199,000
Q2 2022

Jul 28, 2022

BUY
$115.91 - $214.48 $92,728 - $171,584
800 New
800 $153,000

Others Institutions Holding SWAV

About Shockwave Medical, Inc.


  • Ticker SWAV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,927,100
  • Description
  • ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease ...
More about SWAV
Track This Portfolio

Track Avestar Capital, LLC Portfolio

Follow Avestar Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avestar Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Avestar Capital, LLC with notifications on news.